Inhibition of anastomotic intimal hyperplasia by a synthetic nonsulphated heparin-mimicking compound

about

Inhibition of anastomotic intimal hyperplasia by a synthetic nonsulphated heparin-mimicking compound

Item

http://www.wikidata.org/entity/Q37284659

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2002

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibition of anastomotic inti ...... ted heparin-mimicking compound

@en

Inhibition of anastomotic inti ...... ed heparin-mimicking compound.

@nl

type

Item

label

Inhibition of anastomotic inti ...... ted heparin-mimicking compound

@en

Inhibition of anastomotic inti ...... ed heparin-mimicking compound.

@nl

prefLabel

Inhibition of anastomotic inti ...... ted heparin-mimicking compound

@en

Inhibition of anastomotic inti ...... ed heparin-mimicking compound.

@nl

P1476

Inhibition of anastomotic inti ...... ted heparin-mimicking compound

@en

P2093

Annete Schmidt

http://www.w3.org/2001/XMLSchema#string

Arnon Nagler

http://www.w3.org/2001/XMLSchema#string

Erick Buddecke

http://www.w3.org/2001/XMLSchema#string

Gideon Merin

http://www.w3.org/2001/XMLSchema#string

Israel Vlodavsky

http://www.w3.org/2001/XMLSchema#string

Nicola Viola

http://www.w3.org/2001/XMLSchema#string

Shmuel A Ben-Sasson

http://www.w3.org/2001/XMLSchema#string

Yaron Shargal

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

Effects of the heparin-mimicking compound RG-13577 on lipoprotein lipase and on lipase mediated binding of LDL to cells

The pathogenesis of atherosclerosis: a perspective for the 1990s

A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation.

Coated stents: local pharmacology.

Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.

Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor

Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty.

Migration of smooth muscle and endothelial cells. Critical events in restenosis.

Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group.

P304

73-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19649227

http://www.w3.org/2001/XMLSchema#string

P932

2719179

http://www.w3.org/2001/XMLSchema#string